Providing guidance for genomics-based cancer treatment decisions: Insights from stakeholder engagement for post-prostatectomy radiation therapy

Medicine & Life Sciences

• Stakeholder Participation 100%
• Prostatectomy 68%
• Genomics 68%
• Radiotherapy 46%
• Decision Support Techniques 44%
• Neoplasms 21%
• Shared Decision Making 18%
• Acquired Immunodeficiency Syndrome 12%
• Prostatic Neoplasms 11%
• Comorbidity 11%
• Communication 11%
• Therapeutics 11%
• Radiation Oncologists 9%
• Informatics 9%
• Privacy 8%
• Recurrence 8%
• Quality-Adjusted Life Years 8%
• Industry 6%
• Decision Making 6%
• Appointments and Schedules 6%
• Surgeons 5%

Engineering & Materials Science

• Oncology 90%
• Radiotherapy 83%
• Genomics 69%
• Decision making 24%
• Design aids 15%
• Decision theory 13%
• Bioinformatics 12%
• Communication 11%
• Radiation 8%
• Feedback 7%
• Composite materials 6%
• Testing 5%
• Industry 4%

Social Sciences

• treatment decisions 92%
• cancer 61%
• stakeholder 46%
• decision aid 32%
• comorbidity 18%
• decision making 14%
• AIDS 12%
• formatting 10%
• life years 9%
• communication 7%
• privacy 6%
• electronics 5%
• industry 4%
• interaction 3%
• Group 2%